Chemaphor Announces Management Change
Wednesday, 28 September 2011 08:06 PM
OTTAWA, CANADA, September 28, 2011 -Chemaphor Inc. (TSX Venture: CFR) today announced that David Croucher has resigned his position as Chief Financial Officer in order to dedicate his attention full time to a position with another issuer. Mr. Croucher had previously been working on a part time, as-needed basis with Chemaphor.
David Hankinson, Chemaphor's CEO commented, "I want to thank David Croucher for his service and dedication to Chemaphor. Dave has been working with Chemaphor since early 2006 and on behalf of the board of directors I wish him all the best."
Chemaphor will begin a search for a replacement Chief Financial Officer immediately.
About Chemaphor
Chemaphor, a wellness company, is committed to developing and delivering products to humans and animals to assist in optimizing health and daily quality of life. Chemaphor is advancing product candidates for the food animal market, companion animal market and various, potential human applications. More information can be found at www.chemaphor.com.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
For further information contact:
------------------------------------------------------- |Chemaphor Inc. |Investor Relations | |Graham Burton |Sylvain Archambault | |613-990-0969 |President | |[email protected]|Evolution Group Inc. | | |Tel.: 1-866-703-4887 | | |[email protected]| -------------------------------------------------------
